Aratana Therapeutics, Inc. PETX, a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals, today announced that data and observational studies resulting from the Company's extensive clinical development pipeline will be featured in multiple oral and poster presentations during the 2015 American College of Veterinary Internal Medicine Forum (ACVIM) in Indianapolis, IN. The 2015 ACVIM Forum is being held June 3-6, 2015 at the Indiana Convention Center to advance the growth and science of veterinary and animal care.
Showcasing its growing leadership in the development and commercialization of pet medications, Aratana's advancements in the treatment of pet oncology, inappetence and pain will be the subject of 11 presentations during the 2015 ACVIM Forum. The presentations will be given by veterinary industry experts over the course of the four-day conference:
Cancer Therapies and Clinical Studies
Title:
The Evolving Science of Immunotherapeutics in Veterinary Oncology
Date:
Thursday, June 4, 2015
Time/Type:
10:30 am – 11:20 am (Eastern Time) – CE Presentation
Location:
Indiana Convention Center – Sagamore 7
Presenter:
Philip J. Bergman, DVM, Ph.D., DACVIM (Oncology); and Chad Johannes,
DVM, DACVIM (SAIM, Oncology)
Title:
A Prospective, Open-Label Study Evaluating Treatment of Canine B-cell Lymphoma with L-Asparaginase, Doxorubicin and a Canine Anti-CD20 Monoclonal Antibody
Date:
Thursday, June 4, 2015
Time/Type:
11:00 am – 11:15 am (Eastern Time) – Abstract Presentation
Location:
Indiana Convention Center – Room 233
Presenter:
Carlos O. Rodriguez, Jr., DVM, Ph.D., DACVIM (Oncology)
Title:
Clinical Application of Immunotherapeutics in Veterinary Oncology
Date:
Thursday, June 4, 2015
Time/Type:
11:30 am – 12:20 pm (Eastern Time) – CE Presentation
Location:
Indiana Convention Center – Sagamore 7
Presenter:
Philip J. Bergman, DVM, Ph.D., DACVIM (Oncology); and Chad Johannes,
DVM, DACVIM (SAIM, Oncology)
Title:
Anti-CD20 Monoclonal Antibody Canine Lymphoma Therapy: A Double-Blind, Randomized, Placebo-Controlled Study
Date:
Friday, June 5, 2015
Time/Type:
5:25 pm – 5:50 pm (Eastern Time) – Research Report Presentation
Location:
Indiana Convention Center – Room 201
Presenter:
Gregory Ogilvie, DACVIM (SAIM, Oncology), DECVIM-CA (Oncology)
Title:
Combination Listeria-Based Immunotherapy Plus Palliative Radiation Delays Tumor Progression and Prolongs Overall Survival in Canine Osteosarcoma
Date:
Saturday, June 6, 2015
Time/Type:
8:00 am (Eastern Time) – Late-Breaking Abstract Presentation
Location:
Indiana Convention Center – Room 204
Presenter:
Nicola Mason, BVetMed, Ph.D., DACVIM (SAIM)
Inappetence Solutions in Development
Title:
Safety of the Ghrelin Agonist, Capromorelin, Administered Daily to Beagle Dogs for One Year
Date:
Thursday, June 4, 2015
Time/Type:
10:30 am – 10:45 am (Eastern Time) – Abstract Presentation
Location:
Indiana Convention Center – Room 231
Presenter:
Linda Rhodes, VMD, Ph.D.
Title:
Capromorelin, An Orally Active Ghrelin Agonist, Caused Sustained Increases in IGF-1, Increased Food Intake and Body Weight in Cats
Date:
Friday, June 5, 2015
Time/Type:
6:00 pm – 7:30 pm (Eastern Time) – Abstract Poster Session
Location:
Indiana Convention Center – Hall C
Presenter:
Bill Zollers, Ph.D.
Title:
Safety of the Ghrelin Agonist, Capromorelin, Administered to Cats for 91 Days at an Oral Dose of 6 mg/kg
Date:
Friday, June 5, 2015
Time/Type:
6:00 pm – 7:30 pm (Eastern Time) – Abstract Poster Session
Location:
Indiana Convention Center – Hall C
Presenter:
Julie Allen, BVMS, MS, MRCVS, DACVIM (SAIM)
Title:
New Therapeutic Advances in Inappetence for Pets
Date:
Friday, June 5, 2015
Time/Type:
6:30 am – 8:00 am (Eastern Time) – Special Breakfast Session
Location:
Indiana Convention Center – Room 123-124
Presenter:
Audrey Cook, BVM&S, MRCVS, DACVIM, (SAIM), DECVIM (CA), DABVP
(Feline); and Julie Allen, BVMS, MS, MRCVS, DACVIM (SAIM)
Pain Management Treatment Advances
Title:
Introduction to the Emerging Piprant Therapeutic Class of Prostanoid Receptor Antagonists
Date:
Friday, June 5, 2015
Time/Type:
9:00 am – 9:50 am (Eastern Time) – CE Presentation
Location:
Indiana Convention Center – Sagamore 1
Presenter:
Kristin Kirkby Shaw, DVM, MS, Ph.D., DACVS, DACVSMR
Title:
Safety and Toxicokinetic Profiles in Cats Administered Grapiprant, A Selective Prostaglandin-Receptor Antagonist
Date:
Friday, June 5, 2015
Time/Type:
6:00 pm – 7:30 pm (Eastern Time) – Abstract Poster Session
Location:
Indiana Convention Center – Hall C
Presenter:
Lesley Rausch-Derra, DVM, MS
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in